Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: BioCryst Pharmaceuticals Inc., 3 years.
BioCryst Pharmaceuticals Inc.
Director
Aclaris Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 11, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +15,294 | — | — |
| Jun 5, 2026 | Aclaris Therapeutics Inc. | Option exercise | +11,580 | — | — |
| May 29, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +1,122 | $8.91 | $9,997 |
| Feb 27, 2026 | BioCryst Pharmaceuticals Inc. | Grant or award | +848 | $8.75 | $7,420 |
| Nov 28, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +783 | $7.18 | $5,622 |
| Aug 29, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +676 | $8.31 | $5,618 |
| Jun 12, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +12,500 | — | — |
| Jun 6, 2025 | Aclaris Therapeutics Inc. | Option exercise | +4,793 | — | — |
| May 30, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +523 | $10.75 | $5,622 |
| Feb 28, 2025 | BioCryst Pharmaceuticals Inc. | Grant or award | +653 | $8.61 | $5,622 |
| Nov 29, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +750 | $7.50 | $5,625 |
| Aug 30, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +647 | $8.69 | $5,622 |
| Jun 12, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +6,820 | — | — |
| Jun 1, 2024 | Aclaris Therapeutics Inc. | Option exercise | +4,660 | — | — |
| May 31, 2024 | BioCryst Pharmaceuticals Inc. | Grant or award | +870 | $6.46 | $5,620 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.